This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
17 Nov 2021  |  Global  |  Mega Trends
Global Pharmaceutical Packaging Growth Opportunities
The Growing Pipeline of Temperature-sensitive Biologics Products and Healthcare Stakeholders’ Higher Stake in Patient Health Outcomes will Drive Investments
The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...
$2,450.00 -
13 May 2021  |  Global  |  Mega Trends
Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market
Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...
$4,950.00 -
23 Oct 2020  |  Global  |  Mega Trends
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00 -
21 Aug 2020  |  Global  |  Mega Trends
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new...
$4,950.00 -
06 Feb 2018  |  Global  |  Mega Trends
Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020
Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows
The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...
$4,950.00 -
19 May 2017  |  Global  |  Technology Alert
Innovations in Medical Device Technologies
The latest issue of the Medical Devices TOE profiles innovations across the innovation ecosystem and the breadth of the medical devices industry. These include innovations from university research labs, start-up companies, corporations and findings from clinical trials. The innovations come from diverse fields such as super-capacitors for implantab...
$950.00 -
19 May 2017  |  Global  |  Technology Alert
Recent Advances in Cancer Immunotherapy and Tumor Profiling Technologies
Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm shift can be brought about in how cancer is detec...
$250.00 -
12 May 2017  |  Global  |  Technology Alert
Bioinformatics and Advanced Analytics Powering Drug Discovery
Personalized medicine has brought forth a new avenue for innovation. Currently, genomics is being accelerated into extensive use across drug development and drug discovery. The capability of genomics has brought about the resurgence of biomarkers that could effective patient stratification, ensuring the right drugs are developed to treat a specific...
$950.00 -
12 May 2017  |  Global  |  Technology Alert
Therapeutic Breakthroughs in Multiple Sclerosis
This edition of the Future Tech TOE primarily encompasses comprehensive analyses of key emerging therapies across multiple sclerosis (MS). The service also includes treatment overviews, clinical pipeline analysis, IP and funding analysis, and emerging innovations across MS therapies. Furthermore, the research features the impact of key technology...
$750.00 -
12 May 2017  |  Global  |  Technology Alert
Advancements across Health and Wellness
Innovations across health and wellness are improving the quality of diagnosis and prevention. Currently, preventative solutions are gaining a wider acceptance, while solutions like probiotics that supplement the nutrition needs of an individual are important for ensuring a healthy population. However, the current state of diagnosis needs to ensure ...
$250.00